Metropolitan Life Insurance Company (MetLife)’s Oracle ORCL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-64,305	Closed	-$8.08M	–	1480
2024 Q1	$8.08M	Sell	64,305 -368	-0.6%	-$42.1K	0.35%	46
2023 Q4	$6.82M	Sell	64,673 -461	-0.7%	-$50.3K	0.32%	50
2023 Q3	$6.9M	Sell	65,134 -1,929	-3%	-$223K	0.36%	46
2023 Q2	$7.99M	Sell	67,063 -1,677	-2%	-$173K	0.39%	46
2023 Q1	$6.39M	Sell	68,740 -18,019	-21%	-$1.58M	0.33%	57
2022 Q4	$7.09M	Sell	86,759 -463	-0.5%	-$35.2K	0.32%	64
2022 Q3	$5.33M	Sell	87,222 -4,282	-5%	-$313K	0.25%	81
2022 Q2	$6.39M	Sell	91,504 -2,421	-3%	-$177K	0.28%	71
2022 Q1	$7.77M	Sell	93,925 -159,590	-63%	-$12.9M	0.28%	71
2021 Q4	$22.1M	Sell	253,515 -13,226	-5%	-$1.24M	0.3%	57
2021 Q3	$23.2M	Sell	266,741 -29,360	-10%	-$2.59M	0.34%	49
2021 Q2	$23M	Sell	296,101 -15,460	-5%	-$1.21M	0.32%	51
2021 Q1	$21.9M	Sell	311,561 -25,307	-8%	-$1.64M	0.33%	53
2020 Q4	$21.8M	Sell	336,868 -20,426	-6%	-$1.22M	0.33%	53
2020 Q3	$21.3M	Sell	357,294 -36,243	-9%	-$2.06M	0.36%	49
2020 Q2	$21.8M	Sell	393,537 -18,902	-5%	-$1M	0.39%	47
2020 Q1	$19.9M	Sell	412,439 -9,085	-2%	-$469K	0.41%	44
2019 Q4	$22.3M	Sell	421,524 -21,141	-5%	-$1.16M	0.36%	53
2019 Q3	$24.4M	Buy	442,665 +68,285	+18%	+$3.77M	0.41%	40
2019 Q2	$21.3M	Buy	374,380 +11,464	+3%	+$620K	0.36%	50
2019 Q1	$19.5M	Buy	362,916 +129	+0%	+$6.57K	0.35%	54
2018 Q4	$16.4M	Sell	362,787 -59,187	-14%	-$2.84M	0.33%	57
2018 Q3	$21.8M	Sell	421,974 -36,313	-8%	-$1.76M	0.37%	47
2018 Q2	$20.2M	Sell	458,287 -16,168	-3%	-$745K	0.33%	55
2018 Q1	$21.7M	Sell	474,455 -274	-0.1%	-$13.6K	0.31%	47
2017 Q4	$22.4M	Sell	474,729 -960,090	-67%	-$47.1M	0.3%	49
2017 Q3	$69.4M	Sell	1,434,819 -19,043	-1%	-$948K	0.43%	40
2017 Q2	$72.9M	Sell	1,453,862 -39,554	-3%	-$1.8M	0.5%	37
2017 Q1	$66.6M	Sell	1,493,416 -22,473	-1%	-$936K	0.46%	38
2016 Q4	$58.3M	Sell	1,515,889 -45,450	-3%	-$1.78M	0.42%	40
2016 Q3	$61.3M	Sell	1,561,339 -62,311	-4%	-$2.54M	0.45%	39
2016 Q2	$66.5M	Sell	1,623,650 -115,121	-7%	-$4.6M	0.49%	37
2016 Q1	$71.1M	Sell	1,738,771 -55,096	-3%	-$2.04M	0.55%	34
2015 Q4	$65.5M	Sell	1,793,867 -47,065	-3%	-$1.8M	0.5%	36
2015 Q3	$66.5M	Buy	1,840,932 +1,054	+0.1%	+$40.5K	0.48%	38
2015 Q2	$74.1M	Sell	1,839,878 -65,190	-3%	-$2.83M	0.52%	33
2015 Q1	$82.2M	Sell	1,905,068 -38,927	-2%	-$1.69M	0.6%	29
2014 Q4	$87.4M	Sell	1,943,995 -21,969	-1%	-$894K	0.6%	27
2014 Q3	$75.3M	Sell	1,965,964 -129,931	-6%	-$5.26M	0.54%	31
2014 Q2	$84.9M	Sell	2,095,895 -119,942	-5%	-$4.94M	0.59%	23
2014 Q1	$90.7M	Sell	2,215,837 -73,183	-3%	-$2.79M	0.63%	21
2013 Q4	$87.6M	Sell	2,289,020 -52,841	-2%	-$1.82M	0.62%	24
2013 Q3	$77.7M	Sell	2,341,861 -83,099	-3%	-$2.7M	0.59%	26
2013 Q2	$74.5M	Buy	+2,424,960	New	+$80.5M	0.59%	28

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ORCL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Oracle (ORCL) in Q2 2024, closing a stake of 64,305 shares — an estimated $8.08M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ORCL in Q2 2013 and held it in 44 quarters. The position peaked at $90.7M in Q1 2014. 2,917 funds tracked by Wall St. Rank hold ORCL as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Oracle position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 64,305 Oracle shares in Q2 2024, an estimated $8.08M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Oracle in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Oracle position peaked at $90.7M in Q1 2014.
2,917 funds tracked by Wall St. Rank held Oracle as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.